Back
Corcept Therapeutics Stock Price Chart
Buy
81
CORT
Corcept Therapeutics
Last Price:
27.54
Seasonality Move:
8.36%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.32 | Buy |
| 20-day SMA: | 24.46 | Buy |
| 50-day SMA: | 24.36 | Buy |
| 200-day SMA: | 26.67 | Buy |
| 8-day EMA: | 26.58 | Buy |
| 20-day EMA: | 25.29 | Buy |
| 50-day EMA: | 24.59 | Buy |
| 200-day EMA: | 25.13 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 71.13 | Buy |
| Chaikin Money Flow: | -353606 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.5 - 25.98) | Buy |
| Bollinger Bands (100): | (21.98 - 26.88) | Buy |
Corcept Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 27.83 while CORT 8-day simple moving average is 26.32, which is a Buy signal.
- The stock price of CORT is 27.83 while Corcept Therapeutics 20-day SMA is 24.46, which makes it a Buy.
- Corcept Therapeutics 50-day simple moving average is 24.36 while CORT share price is 27.83, making it a Buy technically.
- CORT stock price is 27.83 and Corcept Therapeutics 200-day simple moving average is 26.67, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
81
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a Buy
The current Corcept Therapeutics [CORT] share price is $27.83. The Score for CORT is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
27.83
Share Volume:
682.54K
Corcept Therapeutics 52-Week Range
52-Week High:
34.28
52-Week Low:
20.84
Buy
81
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?
The Corcept Therapeutics stock price is 27.83 USD today. -
Will CORT stock go up or go down?
Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Corcept Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 27.83 while CORT 8-day exponential moving average is 26.58, which is a Buy signal.
- The stock price of CORT is 27.83 while Corcept Therapeutics 20-day EMA is 25.29, which makes it a Buy.
- Corcept Therapeutics 50-day exponential moving average is 24.59 while CORT share price is 27.83, making it a Buy technically.
- CORT stock price is 27.83 and Corcept Therapeutics 200-day simple moving average is 25.13, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.05 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
- CORT Moving Average Covergence Divergence (MACD) indicator is 0.97, suggesting Corcept Therapeutics is a Buy
- Corcept Therapeutics Relative Strength Index (RSI) is 71.13, which suggest Corcept Therapeutics is overbought
- The Bollinger Bands (25) for Corcept Therapeutics is (22.5 - 25.98), which suggest Corcept Therapeutics is a Buy
- The Bollinger Bands (100) for Corcept Therapeutics is (21.98 - 26.88), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.